Acadia Healthcare (NASDAQ:ACHC) Price Target Raised to $28.00

Acadia Healthcare (NASDAQ:ACHC) had its price objective raised by Royal Bank Of Canada from $17.00 to $28.00 in a research report released on Thursday,Benzinga reports. The firm currently has an outperform rating on the stock.

ACHC has been the topic of a number of other research reports. UBS Group reduced their target price on Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating on the stock in a report on Wednesday, December 3rd. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, January 21st. Cantor Fitzgerald set a $17.00 price objective on shares of Acadia Healthcare in a report on Wednesday, December 3rd. Guggenheim cut their target price on shares of Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating on the stock in a report on Monday, February 23rd. Finally, Leerink Partners boosted their price target on shares of Acadia Healthcare from $14.00 to $22.00 and gave the company a “market perform” rating in a report on Thursday. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $20.69.

Acadia Healthcare Price Performance

ACHC opened at $23.44 on Thursday. The company has a fifty day moving average price of $14.82 and a two-hundred day moving average price of $18.56. The firm has a market capitalization of $2.16 billion, a PE ratio of -1.92, a P/E/G ratio of 8.06 and a beta of 0.89. Acadia Healthcare has a 52 week low of $11.43 and a 52 week high of $33.58. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.44 and a current ratio of 1.55.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.04. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The business had revenue of $821.46 million for the quarter, compared to analyst estimates of $800.10 million. During the same period last year, the company earned $0.64 EPS. The firm’s revenue was up 6.1% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Large investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. boosted its position in shares of Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after buying an additional 3,815,471 shares during the period. Jefferies Financial Group Inc. bought a new stake in Acadia Healthcare in the 4th quarter valued at approximately $47,960,000. Wellington Management Group LLP boosted its position in Acadia Healthcare by 24.9% during the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after acquiring an additional 2,350,760 shares during the last quarter. Abrams Bison Investments LLC grew its stake in shares of Acadia Healthcare by 96.7% during the 2nd quarter. Abrams Bison Investments LLC now owns 3,580,000 shares of the company’s stock worth $81,230,000 after acquiring an additional 1,760,000 shares in the last quarter. Finally, Invenomic Capital Management LP raised its holdings in shares of Acadia Healthcare by 71.0% in the fourth quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock valued at $46,998,000 after purchasing an additional 1,375,647 shares during the last quarter.

Acadia Healthcare News Summary

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Q4 revenue topped estimates and EPS beat consensus, driving a strong intraday jump; management provided FY2026 and Q1 2026 guidance that gave investors a clearer outlook. Acadia Healthcare’s (NASDAQ:ACHC) Q4 CY2025 Sales Top Estimates, Stock Jumps 10.8%
• Positive Sentiment: The company posted its Q4 earnings presentation and materials, helping investors parse revenue mix, margin drivers and the path to management’s FY26 targets. Acadia Healthcare Company, Inc. 2025 Q4 – Results – Earnings Call Presentation
• Positive Sentiment: Multiple brokerages raised price targets and maintain buy/outperform stances—RBC to $28 (outperform), UBS to $27 (buy) and TD Cowen to $24 (buy)—which increases buy-side conviction and likely supported the rally. Benzinga: Analyst Price-Target Updates
• Positive Sentiment: Analysts and commentary highlighted improving execution and embedded EBITDA opportunities under returning management, reinforcing the view that operational fixes could restore profitability. TipRanks: Buy Rating on Improving Execution
• Neutral Sentiment: Aggregated analyst coverage: a Benzinga deep-dive summarizes 17 analyst ratings and consensus perspectives — useful for context on how Street expectations are shifting but not a single catalyst. Acadia Healthcare Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)
• Negative Sentiment: Short interest remains very large (~32.45M shares as of mid‑Feb, ~35.9% of float) with a ~7.3 days-to-cover ratio — this high short position increases the risk of volatile trading, squeezes, or pressure if execution disappoints. (short-interest reports summarized in filings and market data)

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.